The inhibitory effect of prostaglandin E2 on rat neutrophil aggregation

Journal of Leukocyte Biology

Volumn 60, Issue 4, 1996, Pages 480-486

  Wise, Helen ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

cAMP; Phosphatidylinositol 3 kinase

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; CYCLIC AMP; ENZYME INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; ROLIPRAM;

ANIMAL CELL; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029962724     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.4.480     Document Type: Article

References (45)

1. 2+ efflux. Biochem. J. 264, 357-364.
2. Winder, A. C. J., Mullen, P. G., Fowler, A. A., Sugerman, H. J. (1993) Role of the neutrophil in adult respiratory distress syndrome. Br. J. Surg. 80, 10-17.
3. Hoffstein, S. T., Friedman, R. S., Weissmann, G. (1982) Degranulation, membrane addition, and shape change during chemotactic factor-induced aggregation of human neutrophils. J. Cell Biol. 95, 234-241.
4. Anderson, D. C., Miller, L. J., Schmalstieg, F. C., Rothlein, R., Springer, T. A. (1986) Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J. Immunol. 137, 15-27.
5. Simon, S. I., Rochon, Y. P., Lynam, E. B., Smith, C. W., Anderson, D. C., Sklar, L. A. (1993) β2-Integrin and L-selectin are obligatory receptors in neutrophil aggregation. Blood 82, 1097-1106.
6. Bargatze, R. F., Kurk, S., Butcher, E. C., Jutila, M. A. (1994) Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J. Exp. Med. 180, 1785-1792.
7. Mease, A. D., Burgess, D. P., Thomas, P. J. (1981) Irreversible neutrophil aggregation. Am. J. Pathol. 104, 98-102.
8. Schwartz, B. R., Ochs, H. D., Beatty, P. G., Harlan, J. M. (1985) A monoclonal antibody-defined membrane antigen complex is required for neutrophil-neutrophil aggregation. Blood 65, 1553-1556.
9. Pedrinaci, S., Huelin, C., Patarroyo, M., Ruiz-Cabello, F., Garrido, F. (1989) Studies on CD11a and CD18 molecules with two new monoclonal antibodies: differential myelomonocytic antigen expression of PMA treated HL60 and U937 cell lines. Hybridoma 8, 13-23.
10. Simon, S. I., Chambers, J. D., Sklar, L. A. (1990) Flow cytometric analysis and modeling of cell-cell adhesive interactions: the neutrophil as a model. J. Cell Biol. 111, 2747-2756.
11. Ford-Hutchinson, A. W., Evans, J. F. (1988) Neutrophil aggregation and chemokinesis assays. Meth. Enzymol. 162, 72-78.
12. Gryglewski, R, J., Salvemini, D. (1992) Modulation of polymorphonuclear leukocyte function by prostaglandins and nitric oxide. In Prostacyclin: New Perspectives for Basic Research and Novel Therapeutic Indications (G. M. Rubanyi and J. Vane, eds.) Amsterdam, Elsevier, 59-92.
13. Harvath, L., Robbins, J. D., Russell, A. A., Seamon, K. B. (1991) cAMP and human neutrophil chemotaxis. J. Immunol. 146, 224-232.
14. 2+. Biochem. J. 224, 629-635.
15. Lad, P. M., Goldberg, B. J., Smiley, P. A., Olsen, C. V. (1985) Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. Biochim. Biophys. Acta 846, 286-295.
16. 2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. Eicosanoids 4, 21-23.
17. Nagata, S., Kebo, D. K., Kunkel, S., Glovsky, M. M. (1992) Effect of adenylate cyclase activators on C5a-induced human neutrophil aggregation, enzyme release and superoxide production. Int. Arch. Allergy Immunol. 97, 194-199.
18. Wheeldon, A., Vardey, C. J. (1993) Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmacol. 108, 1051-1054.
19. Talpain, E., Armstrong, R. A., Coleman, R. A., Vardey, C. (1995) Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br. J. Pharmacol. 114, 1459-1465.
20. Ham, E. A., Soderman, D. D., Zanetti, M. E., Dougherty, H. W., McCauley, E., Kuehl, F. A., Jr. (1983) Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc. Natl. Acad. Sci. USA 80, 4349-4353.
21. Kainoh, M., Imai, R., Umelsu, T., Hattori, M., Nishio, S. (1990) Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes. Biochem. Pharmacol. 39, 477-484.
22. Wise, H., Jones, R. L. (1994) Characterization of prostanoid receptors on rat neutrophils. Br. J. Pharmacol. 113, 581-587.
23. 2, forskolin, and dibutyryl cAMP on arachidonic acid release and inositol phospholipid metabolism in guinea-pig neutrophils. J. Biol. Chem. 261, 1092-1098.
24. 2+ influx. J. Biol. Chem. 270, 23816-23822.
25. 2+-dependent mechanism which is independent of transmembrane activation of adenylate cyclase. J. Biol. Chem. 260, 6769-6775.
26. Coleman, R. A., Smith, W. L., Narumiya, S. (1994) International Union of Pharmacology classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev. 46, 205-229.
27. Wise, H. (1996) The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function. Prostaglandins Leuk. Essen. Fatty Acids 54, 351-360.
28. 2 and selective EP agonists on chemotaxis of human neutrophits. Br. J. Pharmacol. 116, 2903-2908.
29. De Lean, A., Munson, P. J., Rodbard, D. (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am. J. Physiol. 235, E97-E102.
30. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inuoue, T., Naito, K., Toshioka, T., Hidaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromcytoma cells. J. Biol. Chem. 265, 5267-5272.
31. Parker Botelho, L. H., Rothermel, J. D., Coombs, R. V., Jastorff, B. (1988) cAMP analog antagonists of cAMP action. Meth. Enzymol. 159, 159-172.
32. Harris, D. N., Asaad, M. M., Phillips, M. B., Goldenberg, H. J., Antonaccio, M. J. (1979) Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives. J. Cyclic Nucleotide Res. 5, 125-134.
33. 2 may activate ATP sensitive potassium channels in the isolated rat heart. Cardiovasc. Res. 28, 901-905.
34. + channels in cardiac muscle by the sulphonylurea drug glibenclamide. J. Pharmacol. Exp. Ther. 261, 540-545.
35. Vlahos, C. J., Matter, W. F., Brown, R. F., Traynor-Kaplan, A. E., Heyworth, P. G., Prossnitz, E. R., Ye, R. D., Marder, P., Schelm, J. A., Rothfuss, K. J., Serlin, B. S., Simpson, P. J. (1995) Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunol. 154, 2413-2422.
36. i. Naunyn-Schmiedeberg's Arch. Pharmacol. 344, 682-690.
37. Torphy, T. J. (1994) β-Adrenoceptors, cAMP and airway smooth muscle relaxation: challenges to the dogma. Trends Pharmacol. Sci. 15, 370-374.
38. Bevilacqua, M., Vago, T., Baldi, G., Renesto, E., Dallegri, F., Norbiato, G. (1994) Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV, Eur. J. Pharmacol. 268, 415-423.
39. Johnson, M., Sindi, H., Hussain, A., Banks, S. M., Page, C., Costello, J., Kilfeather, S. A. (1995) Inhibition of chemotactic peptide-induced neutrophil superoxide release by theophylline, rolipram and isoprenaline is reduced by protein kinase A anlagonist H89. Br. J. Pharmacol. 114, 29P.
40. Dent, G., Giembycz, M. A., Evans, P. M., Rabe, K. F., Barnes, P. J. (1994) Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol. J. Pharmacol. Exp. Ther. 271, 1167-1174.
41. Seldon, P. M., Barnes, P. J., Giembycz, M. A. (1994) Phosphodiesterase IV inhibitors and β-adrenoceplor agonists suppress lipopolysaccharide-induced tumour necrosis factor-α generation by human peripheral blood monocytes. Br. J. Pharmacol. 112, 215P.
42. Kume, H., Hall, I. P., Washabau, R. J., Takagi, K., Kotlikoff, M. I. (1994) β-Adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J. Clin. Invest. 93, 371-379.
43. Arcaro, A., Wymann. M. P. (1993) Wortmannin is a polent phosphalidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296, 297-301.
44. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., Ui, M. (1994) Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269, 3563-3567.
45. Dewald, B., Thelen, M., Baggiolini, M. (1988) Two transduction sequences are necessary for neutrophil activation by receptor agonists. J. Biol. Chem. 263, 16179-16184.